Literature DB >> 17160721

Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease.

Sofía Sánchez-Iglesias1, Pablo Rey, Estefanía Méndez-Alvarez, José Luis Labandeira-García, Ramón Soto-Otero.   

Abstract

The unilateral and intrastriatal injection of 6-hydroxydopamine is commonly used to provide a partial lesion model of Parkinson's disease in the investigation of the molecular mechanisms involved in its pathogenesis and to assess new neuroprotective treatments. Its capacity to induce neurodegeneration has been related to its ability to undergo autoxidation in the presence of oxygen and consequently to generate oxidative stress. The aim of the present study was to investigate the time course of brain oxidative damage induced by 6-hydroxydopamine (6 microg in 5 microl of sterile saline containing 0.2% ascorbic acid) injection in the right striatum of the rat. The results of this study show that the indices of both lipid peroxidation (TBARS) and protein oxidation (carbonyl and free thiol contents) increase simultaneously in the ipsilateral striatum and ventral midbrain, reaching a peak value at 48-h post-injection for both TBARS and protein carbonyl content, and at 24 h for protein free thiol content. A lower but significant increase was also observed in the contralateral side (striatum and ventral midbrain). The indices of oxidative stress returned to values close to those found in controls at 7-day post-injection. These data show that the oxidative stress is a possible triggering factor for the neurodegenerative process and the retrograde neurodegeneration observed after 1-week post-injection is a consequence of the cell damage caused during the first days post-injection. The optimal time to assess brain indices of oxidative stress in this model is 48-h post-injection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160721     DOI: 10.1007/s11064-006-9232-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Authors:  Lars M Bjorklund; Rosario Sánchez-Pernaute; Sangmi Chung; Therese Andersson; Iris Yin Ching Chen; Kevin St P McNaught; Anna-Liisa Brownell; Bruce G Jenkins; Claes Wahlestedt; Kwang-Soo Kim; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

2.  Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra.

Authors:  M J Marti; C J James; T F Oo; W J Kelly; R E Burke
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

3.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

4.  Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

Authors:  Y He; S Appel; W Le
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

5.  Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.

Authors:  A Lopez-Real; P Rey; R Soto-Otero; E Mendez-Alvarez; J L Labandeira-Garcia
Journal:  J Neurosci Res       Date:  2005-09-15       Impact factor: 4.164

6.  Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration.

Authors:  B Cutillas; M Espejo; J Gil; I Ferrer; S Ambrosio
Journal:  Neuroreport       Date:  1999-08-20       Impact factor: 1.837

7.  Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease.

Authors:  Estefanía Méndez-Alvarez; Ramón Soto-Otero; Alvaro Hermida-Ameijeiras; Ana María López-Real; José Luis Labandeira-García
Journal:  Biochim Biophys Acta       Date:  2002-03-16

8.  Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage.

Authors:  J Luthman; A Fredriksson; E Sundström; G Jonsson; T Archer
Journal:  Behav Brain Res       Date:  1989-07-01       Impact factor: 3.332

9.  Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine.

Authors:  Y Glinka; K F Tipton; M B Youdim
Journal:  Eur J Pharmacol       Date:  1998-06-12       Impact factor: 4.432

10.  Localization of damage induced by reactive oxygen species in cultured cells.

Authors:  S M Vroegop; D E Decker; S E Buxser
Journal:  Free Radic Biol Med       Date:  1995-02       Impact factor: 7.376

View more
  12 in total

Review 1.  Dopamine Receptors and Neurodegeneration.

Authors:  Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

2.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

3.  Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion.

Authors:  Crystal S Bethel-Brown; Hongyu Zhang; Stephen C Fowler; Mark E Chertoff; G Stennis Watson; John A Stanford
Journal:  Pharmacol Biochem Behav       Date:  2010-07-01       Impact factor: 3.533

4.  Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss.

Authors:  A L Spieles-Engemann; M M Behbehani; T J Collier; S L Wohlgenant; K Steece-Collier; K Paumier; B F Daley; S Gombash; L Madhavan; G T Mandybur; J W Lipton; B T Terpstra; C E Sortwell
Journal:  Neurobiol Dis       Date:  2010-03-20       Impact factor: 5.996

5.  Restoring cerebral dopamine homeostasis by electrical forepaw stimulation: an FMRI study.

Authors:  Y Iris Chen; Jia-Qian Ren; Ted J Kaptchuk; Kenneth K Kwong
Journal:  Synapse       Date:  2011-12-29       Impact factor: 2.562

6.  6-Hydroxydopamine: a far from simple neurotoxin.

Authors:  Damir Varešlija; Keith F Tipton; Gavin P Davey; Andrew G McDonald
Journal:  J Neural Transm (Vienna)       Date:  2020-01-01       Impact factor: 3.575

7.  Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra.

Authors:  Rasajna Nadella; Merja H Voutilainen; Mart Saarma; Juan A Gonzalez-Barrios; Bertha A Leon-Chavez; Judith M Dueñas Jiménez; Sergio H Dueñas Jiménez; Lourdes Escobedo; Daniel Martinez-Fong
Journal:  J Neuroinflammation       Date:  2014-12-16       Impact factor: 8.322

8.  Vitamin D attenuated 6-OHDA-induced behavioural deficits, dopamine dysmetabolism, oxidative stress, and neuro-inflammation in mice.

Authors:  Adedamola Bayo-Olugbami; Abdulrazaq Bidemi Nafiu; Abdulbasit Amin; Olalekan Michael Ogundele; Charles C Lee; Bamidele Victor Owoyele
Journal:  Nutr Neurosci       Date:  2020-09-11       Impact factor: 4.994

9.  Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine.

Authors:  Daniel Hernandez-Baltazar; Maria E Mendoza-Garrido; Daniel Martinez-Fong
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 10.  Brain renin-angiotensin system and dopaminergic cell vulnerability.

Authors:  Jose L Labandeira-García; Pablo Garrido-Gil; Jannette Rodriguez-Pallares; Rita Valenzuela; Ana Borrajo; Ana I Rodríguez-Perez
Journal:  Front Neuroanat       Date:  2014-07-08       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.